Search

everythinglearnresearchcommunity

for

Search:↓

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Certain gene variants can influence acne risk and severity.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Drug repositioning can save time and money but needs more support.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

Suppressing eIF4E can prevent hair loss from chemotherapy.

PCL nanoscaffold-based liver spheroids are effective for drug screening and studying liver toxicity.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

COVID-19 treatments and vaccines face challenges due to genetic differences in people and the virus.

The study successfully formulated and optimized a bilayer tablet combining Tamsulosin and Finasteride using response surface methodology.

Chemotherapy damages hair follicles, causing hair loss and other cellular changes.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

Natural volatiles and essential oils have health benefits and can enhance the effects of some medicines, but more research is needed to understand how they work and their possible side effects.

PCOS is influenced by various factors and may be managed by restoring gut health and using new therapies.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.